Stathmin is over expressed in metastatic prostate cancer: Implications in prostate cancer progression

被引：0
|
作者：
Mehra, R [1 ]
Poisson, L [1 ]
Varambally, S [1 ]
Tomlins, S [1 ]
Kunju, L [1 ]
Ghosh, D [1 ]
Chinnaiyan, A [1 ]
Shah, RB [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
689
引用
收藏
页码：149A / 150A
页数：2
相关论文
共 50 条
  • [41] Stat3 promotes metastatic progression of prostate cancer
    Abdulghani, Junaid
    Gu, Lei
    Dagvadorj, Ayush
    Lutz, Jacqueline
    Leiby, Benjamin
    Bonuccelli, Gloria
    Lisanti, Michael P.
    Zellweger, Tobias
    Alanen, Kalle
    Mirtti, Tuomas
    Visakorpi, Tapio
    Bubendorf, Lukas
    Nevalainen, Marja T.
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (06): : 1717 - 1728
  • [42] Differential expression of osteocalcin during the metastatic progression of prostate cancer
    Gardner, Thomas A.
    Lee, Sang-Jin
    Lee, Sang-Don
    Li, Xiong
    Shirakawa, Toshihiro
    Kwon, Dong Deuk
    Park, Ra Young
    Ahn, Kyu Youn
    Jung, Chaeyong
    ONCOLOGY REPORTS, 2009, 21 (04) : 903 - 908
  • [43] MEIS PROTEINS AS PREDICTIVE MARKERS OF METASTATIC PROSTATE CANCER PROGRESSION
    Bhanvadia, Raj
    McAuley, Erin
    Chan, Wen-Ching
    Brechka, Hannah
    Paner, Gladell
    Vander Griend, Donald
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1167 - E1167
  • [44] Nano therapeutic approaches to combat progression of metastatic prostate cancer
    Thakur, Abhimanyu
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2021, 2
  • [45] Tracking clonal diversity in metastatic prostate cancer progression.
    Hovens, Christopher
    Hong, Matthew
    Macintyre, Geoff
    Wedge, David
    Van Loo, Peter
    Lunke, Sebastian
    Alexandrov, Ludmil
    Slogget, Clare
    Cmero, Marek
    Mangiola, Steafano
    Lonie, Andrew
    Naeem, Haroon
    Sapre, Nikhil
    Phal, Pramit
    Kerger, Michael
    Pedersen, John
    Ryan, Andrew
    Haviv, Izhak
    Costello, Anthony
    Corcoran, Niall
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [46] Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression
    Vaarala, MH
    Porvari, K
    Kyllönen, A
    Vihko, P
    LABORATORY INVESTIGATION, 2000, 80 (08) : 1259 - 1268
  • [47] Snail1 is over-expressed in prostate cancer
    Heeboll, Sara
    Borre, Michael
    Ottosen, Peter David
    Dyrskjot, Lars
    Orntoft, Torben Falck
    Torring, Niels
    APMIS, 2009, 117 (03) : 196 - 204
  • [48] Stathmin 1 expression in neuroendocrine and proliferating prostate cancer
    Shi, Yingli
    Yeh, Yunshin A.
    Cheng, Siyuan
    Gu, Xin
    Yang, Shu
    Li, Lin
    Khater, Nazih P.
    Kasper, Susan
    Yu, Xiuping
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [49] Progression of metastatic prostate cancer into castrate resistant prostate cancer (mCRPC): a real-world experience in a multi-ethnic prostate cancer patients cohort
    Low, J. Q. L.
    Lim, J.
    Chai, C. A.
    Gan, C. W.
    Aung, K. P.
    Ong, T. A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 178 - 178
  • [50] Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression
    Cox, ME
    Deeble, PD
    Lakhani, S
    Parsons, SJ
    CANCER RESEARCH, 1999, 59 (15) : 3821 - 3830
12345